Heartflow
在场
是其中之一......
Heartflow 是一家在股票代码 HFLO (US) 下上市的公司。
涉及Heartflow的并购和融资。
- Heartflow 凭借他的 215 百万美元筹款活动成为了独角兽。 (公布2023四月11号).
高管
查看带有其 23 名主要高管的组织结构图
Heartflow 搜索最多的简介
- John Farquhar, President and Chief Executive Officer
- Casey Tansey, Director
- Jeffrey Lightcap, Director
创建提醒
跟踪 Heartflow 的高管变动
医疗设备
Heartflow 拥有 1,005 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。
Popular M&A news in 医疗设备
- Precision Neuroscience 刚刚宣布为 102 筹款数百万美元。 (公布2024十二月18号).
- electroCore 已收购 NeuroMetrix (公布2024十二月18号).
- Anteris Technologies 刚刚宣布为 89 筹款数百万美元。 (公布2024十二月16号).
医疗设备 行业的其他推荐联系人
消息
Heartflow 的最新新闻稿
- ACC 2019 News: ADVANCE Registry Outcomes | HeartFlow
- FFRCT RIPCORD Study: Availability of HeartFlow FFRCT Analysis Changes the Management of Patients with Coronary Artery Disease | HeartFlow
- TCT 2019 News: HeartFlow Planner & Cost-effectiveness Analysis | HeartFlow
- EuroPCR 2019 News: BOWIE Study | HeartFlow
- Late-breaking Data Demonstrate AHA/ACC Guideline-directed CCTA + FFRCT Precision Pathway is Superior to Traditional Testing | HeartFlow
- HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
- Positive Long-term Outcomes with HeartFlow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024
- HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
- HeartFlow Announces Favorable Coverage Determination for Plaque Analysis by Four Medicare Administrative Contractors
- HeartFlow to Present Latest Data on AI-Enabled Coronary Artery Disease Management at TCT 2024
- View more press releases Close
关于 Heartflow 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 John Farquhar 
